Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation
暂无分享,去创建一个
[1] P. Beisswenger. Glycation and biomarkers of vascular complications of diabetes , 2012, Amino Acids.
[2] Samy Suissa,et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.
[3] A. Krolewski,et al. Early nephropathy in type 1 diabetes: the importance of early renal function decline , 2009, Current opinion in nephrology and hypertension.
[4] W. Cefalu,et al. Glycemic targets and cardiovascular disease. , 2008, The New England journal of medicine.
[5] G. McMahon,et al. Intensive glycemic control in the ACCORD and ADVANCE trials. , 2008, The New England journal of medicine.
[6] L. Monnier,et al. Contributions of fasting and postprandial glucose to hemoglobin A1c. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[7] R. Nelson,et al. Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. , 2005, Diabetes.
[8] Paul J Thornalley,et al. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. , 2005, Diabetes care.
[9] M. Kramer,et al. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. , 2005, Diabetes.
[10] Paul J Thornalley,et al. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes , 2005, Diabetologia.
[11] S. Genuth,et al. Glycation Products as Markers and Predictors of the Progression of Diabetic Complications , 2005, Annals of the New York Academy of Sciences.
[12] Michael Brownlee,et al. The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.
[13] M. Hanefeld,et al. Postprandial glucose regulation and diabetic complications. , 2004, Archives of internal medicine.
[14] M. F. Saad,et al. Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus , 1990, Diabetologia.
[15] S. Kreiner,et al. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study , 1983, Diabetologia.
[16] A. Goldberg,et al. Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.
[17] Anne Dawnay,et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. , 2003, The Biochemical journal.
[18] M. Kramer,et al. Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. , 2003, Diabetes.
[19] Matthew D. Davis,et al. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.
[20] Michael E. Miller,et al. Erratum: Cellular basis of diabetic nephropathy. 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes (Diabetes (2002) 51 (506-513) , 2002 .
[21] M. Mauer,et al. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. , 2002, Diabetes.
[22] M. Mauer,et al. The early natural history of nephropathy in type 1 diabetes: I. Study design and baseline characteristics of the study participants. , 2002, Diabetes.
[23] D. Goldstein,et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.
[24] Michael E. Miller,et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. , 2002, Diabetes.
[25] B. Szwergold,et al. alpha-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. , 2001, Diabetes care.
[26] M. Mauer,et al. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? , 2000, Diabetes.
[27] R. Holman,et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.
[28] S. Rich,et al. Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. , 1999, Diabetes.
[29] Clustering of Long-Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial , 1997, Diabetes.
[30] D. Malencik,et al. Dityrosine: preparation, isolation, and analysis. , 1996, Analytical biochemistry.
[31] M. Steffes,et al. Glomerular Structure in Nonproteinuric IDDM Patients With Various Levels of Albuminuria , 1994, Diabetes.
[32] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[33] E. Seaquist,et al. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.
[34] J. Flier,et al. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.
[35] H. Klocker,et al. Measurement of glycated protein by a rapid and specific method for absolute quantification of lysine-bound glucose. , 1987, Clinical chemistry.
[36] C. Mogensen,et al. Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.
[37] D. Wilson,et al. Vitreous fluorophotometry: identification of sources of variability. , 1981, Investigative ophthalmology & visual science.
[38] H. Mcilwain,et al. Preparation and antibacterial action of some compounds structurally related to glutamic acid. Their application in microbiological determination of small quantities of glutamine. , 1948, The Biochemical journal.